Parathyroid Hormone Global Market Report 2023 – By Parathyroid Hormone Global Market Report 2023 – By Disease Type (Hypocalcaemia, Hypoparathyroidism), By End-User (Hospitals, Clinics, Othe End-Users), By Product Type (Recombinant Parathtyoid Hormone, Parathyroid Hormone Analogues) – Market Size, Trends, And Global Forecast 2023-2032 ...(expand)

Parathyroid hormone refers to a substance produced by the parathyroid gland that aids in the body's storage and utilisation of calcium. High blood calcium levels are a result of parathyroid hormone levels that are greater than usual and could be a disease indicator. It is also known as PTH, parathyrin, and parathormone. For further insights on the parathyroid hormone market, request a sample here

The parathyroid hormone market growth is aided by rise in the prevalence of osteoporosis. However, some parathyroid hormone market restraints include product recalls due to quality control issues. For further insights on the parathyroid hormone market, request a sample here

The parathyroid hormone market is expected to reach $2.8 billion in 2027 at a rate of 5.6%. For further insights on the parathyroid hormone market, request a sample here

The global parathyroid hormone market is segmented as
1) By Disease Type: Hypocalcaemia, Hypoparathyroidism
2) By End-User: Hospitals, Clinics, Othe End-Users
3) By Product Type: Recombinant Parathtyoid Hormone, Parathyroid Hormone Analogues
For further insights on the parathyroid hormone market, request a sample here

North America was the largest region in the parathyroid hormone market in 2022. For detailed insights on the largest region's market size and growth rate, request a sample here.

Key competitors in the parathyroid hormone market are, Pfizer Inc, Eli Lilly and Company, Radius Health Inc, Shire, Ascendis Pharma, Entera Bio Ltd, Extend Biosciences Inc, Gedeon Richter Plc. For further insights on the parathyroid hormone market, request a sample here.

Major trends influencing the parathyroid hormone market include focusing on developing biosimilars of parathyroid-based drugs. A biosimilar is a biological product that is developed to be similar to an already FDA-approved biologic, known as the reference product. Biosimilars potentially offer consumers the opportunity to reduce their health care costs without compromising on treatment standards, which is why parathyroid hormone manufacturing companies are investing in them. For further insights on the parathyroid hormone market, request a sample here.

For detailed insights on the major opportunities and strategies in the parathyroid hormone market, request a sample here.

For detailed insights on parathyroid hormone market's relation to the overall economy and other similar markets, request a sample here.

For detailed insights on the mergers and acquisitions in the parathyroid hormone industry, request a sample here.

For detailed insights on the key dynamics influencing the parathyroid hormone market growth and SWOT analysis of the parathyroid hormone industry, request a sample here.